Q4 Results: Sun Pharma declines near 4% amid profit-booking – Check what brokerages have to say
Amid profit booking and lower-than-expected quarter-four estimates, Sun Pharma declined around four per cent to Rs 673 per share at around 2:30 pm on the BSE intraday trade on Friday. The stock is the top laggard in the Nifty Pharma index, which is declined most than its sectoral peers.
Sun Pharma reported a jump of 124 per cent YoY growth in the net profit in Q4: Reuters